Short-chain fatty acids (SCFAs) are products of bacterial fermentation that help maintain important gut functions such as maintenance of the intestinal barrier, cell signaling, and immune homeostasis. The main SCFAs acetate, propionate, and butyrate have demonstrated beneficial effects for the host, including its importance in alleviating infections caused by pathogens such as
Clostridioides difficile
. Despite the potential role of SCFAs in mitigating
C. difficile
infection, their direct effect on
C. difficile
remains unclear. Through a set of
in vitro
experiments, we investigated how SCFAs influence
C. difficile
growth, sporulation, and toxin production. Similar to previous studies, we observed that butyrate decreased growth of
C. difficile
strain 630 in a dose-dependent manner. The presence of butyrate also increased
C. difficile
sporulation, with minimal increases in toxin production. RNA-Seq analysis validated our experimental results, demonstrating increased expression of sporulation-related genes in conjunction with changes in metabolic and regulatory genes, such as a putative carbon starvation protein, CstA. Collectively, these data suggest that butyrate may induce alternative
C. difficile
survival pathways, modifying its growth ability and virulence to persist in the gut environment.
IMPORTANCE
Several studies suggest that butyrate may modulate gut infections, such as reducing inflammation caused by the healthcare-associated
Clostridioides difficile
. While studies in both animal models and human studies correlate high levels of butyrate with reduced
C. difficile
burden, the direct impact of butyrate on
C. difficile
remains unclear. Our study demonstrates that butyrate directly influences
C. difficile
by increasing its sporulation and modifying its metabolism, potentially using butyrate as a biomarker to shift survival strategies in a changing gut environment. These data point to additional therapeutic approaches to combat
C. difficile
in a butyrate-directed manner.